CME Group Inc. $CME Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Key Points

• MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. significantly increased its stake in CME Group by 161.6%, acquiring an additional 104,352 shares for a total holding valued at $44.8 million.
• CME Group reported earnings per share (EPS) of $2.96, surpassing analysts' estimates, with a year-over-year revenue increase of 10.4%.
• The company announced a quarterly dividend of $1.25 per share, with an annualized yield of 1.9%, to be paid on September 25th.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 161.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 168,938 shares of the financial services provider's stock after acquiring an additional 104,352 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in CME Group were worth $44,817,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of CME. Integrated Wealth Concepts LLC lifted its position in shares of CME Group by 9.8% during the first quarter. Integrated Wealth Concepts LLC now owns 2,667 shares of the financial services provider's stock worth $707,000 after purchasing an additional 238 shares during the last quarter. Gotham Asset Management LLC lifted its position in shares of CME Group by 4.9% during the first quarter. Gotham Asset Management LLC now owns 90,205 shares of the financial services provider's stock worth $23,930,000 after purchasing an additional 4,228 shares during the last quarter. Cinctive Capital Management LP bought a new position in shares of CME Group during the first quarter worth about $240,000. Concentric Capital Strategies LP bought a new position in shares of CME Group during the first quarter worth about $1,010,000. Finally, Alliancebernstein L.P. raised its position in shares of CME Group by 185.5% during the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider's stock valued at $330,182,000 after acquiring an additional 808,740 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

CME Group Stock Down 2.1%

NASDAQ:CME opened at $261.94 on Friday. The business's fifty day moving average price is $274.96 and its 200 day moving average price is $269.99. CME Group Inc. has a 1-year low of $212.38 and a 1-year high of $290.79. The firm has a market capitalization of $94.40 billion, a price-to-earnings ratio of 25.36, a PEG ratio of 4.74 and a beta of 0.43. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the firm earned $2.56 EPS. The company's revenue was up 10.4% compared to the same quarter last year. On average, sell-side analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be paid a $1.25 dividend. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group's payout ratio is 48.40%.

Wall Street Analysts Forecast Growth

CME has been the topic of several recent analyst reports. UBS Group reaffirmed a "neutral" rating and set a $305.00 target price on shares of CME Group in a research note on Thursday, July 24th. Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Citigroup increased their price target on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. Finally, Piper Sandler raised their target price on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. Four equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $261.93.

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard bought 256 shares of CME Group stock in a transaction on Wednesday, June 25th. The stock was purchased at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the purchase, the director directly owned 258,196 shares of the company's stock, valued at $69,849,763.88. The trade was a 0.10% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Charles P. Carey sold 500 shares of CME Group stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total transaction of $132,675.00. Following the completion of the sale, the director owned 4,900 shares of the company's stock, valued at $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company's stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.